A citation-based method for searching scientific literature

Barbara Breitenstein, Sandra Scheuer, Florian Holsboer. Drug Discov Today 2014
Times Cited: 33







List of co-cited articles
283 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Biomarkers to predict antidepressant response.
Andrew F Leuchter, Ian A Cook, Steven P Hamilton, Katherine L Narr, Arthur Toga, Aimee M Hunter, Kym Faull, Julian Whitelegge, Anne M Andrews, Joseph Loo,[...]. Curr Psychiatry Rep 2010
83
21


Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.
Stefano Porcelli, Chiara Fabbri, Alessandro Serretti. Eur Neuropsychopharmacol 2012
186
18

Biomarkers predicting antidepressant treatment response: how can we advance the field?
Christiana Labermaier, Mercè Masana, Marianne B Müller. Dis Markers 2013
41
18

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
Heath D Schmidt, Richard C Shelton, Ronald S Duman. Neuropsychopharmacology 2011
245
18


A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
18

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
18

Personalized medicine for depression: can we match patients with treatments?
Gregory E Simon, Roy H Perlis. Am J Psychiatry 2010
167
18

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
18

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
18

Toward a neuroimaging treatment selection biomarker for major depressive disorder.
Callie L McGrath, Mary E Kelley, Paul E Holtzheimer, Boadie W Dunlop, W Edward Craighead, Alexandre R Franco, R Cameron Craddock, Helen S Mayberg. JAMA Psychiatry 2013
252
15

Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
Mary L Phillips, Henry W Chase, Yvette I Sheline, Amit Etkin, Jorge R C Almeida, Thilo Deckersbach, Madhukar H Trivedi. Am J Psychiatry 2015
133
15

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode.
R Belzeaux, A Bergon, V Jeanjean, B Loriod, C Formisano-Tréziny, L Verrier, A Loundou, K Baumstarck-Barrau, L Boyer, V Gall,[...]. Transl Psychiatry 2012
123
12

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
432
12

Depression: an inflammatory illness?
Rajeev Krishnadas, Jonathan Cavanagh. J Neurol Neurosurg Psychiatry 2012
205
12

Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.
Jean-Philippe Guilloux, Sabrina Bassi, Ying Ding, Chris Walsh, Gustavo Turecki, George Tseng, Jill M Cyranowski, Etienne Sibille. Neuropsychopharmacology 2015
34
12

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.
Eric J Peters, Susan L Slager, Greg D Jenkins, Megan S Reinalda, Holly A Garriock, Stanley I Shyn, Jeffrey B Kraft, Patrick J McGrath, Steven P Hamilton. Pharmacogenet Genomics 2009
62
12

SLC6A4 variation and citalopram response.
D A Mrazek, A J Rush, J M Biernacka, D J O'Kane, J M Cunningham, E D Wieben, D J Schaid, M S Drews, V L Courson, K A Snyder,[...]. Am J Med Genet B Neuropsychiatr Genet 2009
94
12

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Asuka Katsuki, Reiji Yoshimura, Taro Kishi, Hikaru Hori, Wakako Umene-Nakano, Atsuko Ikenouchi-Sugita, Kenji Hayashi, Kiyokazu Atake, Nakao Iwata, Jun Nakamura. CNS Spectr 2012
25
16


Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
Francis J McMahon, Silvia Buervenich, Dennis Charney, Robert Lipsky, A John Rush, Alexander F Wilson, Alexa J M Sorant, George J Papanicolaou, Gonzalo Laje, Maurizio Fava,[...]. Am J Hum Genet 2006
282
12

Pretreatment brain states identify likely nonresponse to standard treatments for depression.
Callie L McGrath, Mary E Kelley, Boadie W Dunlop, Paul E Holtzheimer, W Edward Craighead, Helen S Mayberg. Biol Psychiatry 2014
71
12

Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder.
Glenda M MacQueen, Kaan Yucel, Valerie H Taylor, Kathryn Macdonald, Russell Joffe. Biol Psychiatry 2008
133
12

Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.
Gerard E Bruder, James P Sedoruk, Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin, Craig E Tenke. Biol Psychiatry 2008
136
12

The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.
Martin Bares, Martin Brunovsky, Tomas Novak, Miloslav Kopecek, Pavla Stopkova, Peter Sos, Vladimir Krajca, Cyril Höschl. Eur Neuropsychopharmacol 2010
51
12

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.
Ian A Cook, Andrew F Leuchter, Melinda L Morgan, William Stubbeman, Barbara Siegman, Michelle Abrams. J Psychiatr Res 2005
50
12


Frontal EEG predictors of treatment outcome in major depressive disorder.
Dan V Iosifescu, Scott Greenwald, Philip Devlin, David Mischoulon, John W Denninger, Jonathan E Alpert, Maurizio Fava. Eur Neuropsychopharmacol 2009
75
12


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
9

Pharmacogenetics in major depression: a comprehensive meta-analysis.
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2013
127
9

Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
F Mamdani, M T Berlim, M-M Beaulieu, A Labbe, C Merette, G Turecki. Transl Psychiatry 2011
38
9

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
9

The molecular neurobiology of depression.
Vaishnav Krishnan, Eric J Nestler. Nature 2008
9

Human biomarkers of rapid antidepressant effects.
Carlos A Zarate, Daniel C Mathews, Maura L Furey. Biol Psychiatry 2013
67
9

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
9


Analysis of 34 candidate genes in bupropion and placebo remission.
Arun K Tiwari, Clement C Zai, Gautam Sajeev, Tamara Arenovich, Daniel J Müller, James L Kennedy. Int J Neuropsychopharmacol 2013
25
12


BDNF Val66Met genotype and 6-month remission rates in late-life depression.
W D Taylor, D R McQuoid, A Ashley-Koch, J R MacFall, J Bridgers, R R Krishnan, D C Steffens. Pharmacogenomics J 2011
37
9

Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response.
Younger W-Y Yu, Shih-Jen Tsai, Chen-Jee Hong, Tai-Jui Chen, Ming-Chao Chen, Chih-Wei Yang. Neuropsychopharmacology 2005
123
9

Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders.
Yan-Feng Zou, Fang Wang, Xiao-Liang Feng, Wen-Fei Li, Jin-Hui Tao, Fa-Ming Pan, Fen Huang, Hong Su. Neurosci Lett 2010
40
9


Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
Bárbara Arias, Alessandro Serretti, Cristina Lorenzi, Cristóbal Gastó, Rosa Catalán, Lourdes Fañanás. J Affect Disord 2006
76
9

Genetic predictors of response to antidepressants in the GENDEP project.
Rudolf Uher, Patricia Huezo-Diaz, Nader Perroud, Rebecca Smith, Marcella Rietschel, Ole Mors, Joanna Hauser, Wolfgang Maier, Dejan Kozel, Neven Henigsberg,[...]. Pharmacogenomics J 2009
137
9

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Katharina Domschke, Bruce Lawford, Gonzalo Laje, Klaus Berger, Ross Young, Phillip Morris, Jürgen Deckert, Volker Arolt, Francis J McMahon, Bernhard T Baune. Int J Neuropsychopharmacol 2010
76
9


The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
André Tadić, Matthias J Müller, Dan Rujescu, Ralf Kohnen, Hans H Stassen, Norbert Dahmen, Armin Szegedi. Am J Med Genet B Neuropsychiatr Genet 2007
45
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.